Documentos de Académico
Documentos de Profesional
Documentos de Cultura
JOSE RAVELO T. BARTOLOME, MD, FPCS, FPSGS, FPAHNSI ASSISTANT PROFESSOR IN SURGERY DEPARTMENT OF ELECTROLYTES FLUIDS AND SURGERY, FEUNRMF
INSTRUCTIONAL LEARNING OBJECTIVES GENERAL OBJECTIVE: At the end of the course, the student must be able to know the basic principles in the recognition and management of the fluids and electrolyte problems of the surgical patient. SPECIFIC OBJECTIVES:
1.
2.
3.
At the end of the course, the student must be able to: Define the different body fluid compartments as to its: 1. Normal distribution 2. Composition 4/28/12 Identify the different avenues of normal fluid loss
5.
6.
7.
Recognize the three main categories of body fluid changes as to its: 1. Etiology 2. Pathophysiology 3. Clinical manifestations 4. Management Identify specific electrolyte abnormalities associated with body fluid changes as to its: 1. Etiology 2. Pathophysiology 3. Clinical manifestations 4. Management Recognize acid-base disorders associated with body fluid changes as to its: 1. Etiology 2. Pathophysiology 3. Clinical manifestations 4/28/12
4/28/12
4/28/12
4/28/12
4/28/12
higher in infants and children (max. of 75-80% of total body weight in newborn is water)
Lean person has more water; obese
4/28/12
2500 ml
About 1500 ml taken by mouth;
Rule of thumb: 30 ml / kg BW / 24
mainly
and Na / 24 hours =
60
4/28/12
Fluid requirements
typically 35 mL/kg/day insensible loss = 700 mL/day or 0.2
11-20 kg =
4/28/12
loss
CONCENTRATION CHANGES
Changes in the concentration of
VOLUME CHANGES
VOLUME DEFICIT or HYPOVOLEMIA VOLUME EXCESS or HYPERVOLEMIA
Primarily an extracellular fluid (ECF)
compartment phenomenon
History
Laboratory
VOLUME DISTURBANCES
4/28/12
changes
4/28/12
External losses
GIT losses vomiting, NGT suctioning,
Hemorrhage/bleeding
Internal losses
Sequestration Soft-tissue injuries/ infections Intestinal obstruction Intra-abdominal and retroperitoneal
inflammatory process
4/28/12
4/28/12
volume
CNS and CVS effects
CNS effects:
Due to resulting hypernatremia Restlessness to delirium
CVS effects:
Hypotension and tachycardia Decreased skin turgor and dry mucuous 4/28/12
Laboratory tests:
Hemoconcentration = inc. hematocrit Renal insufficiency = elevated BUN &
creatinine
Management:
Volume replacement
Crystalloid Colloidal Blood
(sodium)
Diagnosis:
Mainly by history and physical
examination
Clinical manifestations similar to pure
volume deficit
4/28/12
Classification: Hypovolemia/Hemorrhage
Water Loss MILD 4% of TBW CLASS I Hemorrhage 15% of blood volume 15 30% of blood volume 30 40% of blood volume > 40% of blood
MODERATE
6% of TBW CLASS II
SEVERE
Blood volume = 7.5% of total body weight (approx. 5.0 L) SHOCK > 8% of CLASS IV TBW
4/28/12
COLLOIDAL SOLUTIONS
Starch 4/28/12 BLOOD AND BLOOD COMPONENTS
4/28/12
Resuscitation
Crystalloids
Replace blood loss at a 3:1 ratio Initial bolus 1-2 liters, usually normal
saline
additional fluids. Once 3-4 liters of crystalloid has been given consider blood.
4/28/12
patients
Renal insufficiency Increase or excess in extracellular
renal)
Mobilization of previously
sequestered fluid
4/28/12
(JVP)
Elevated CVP or PCWP Seizures, muscle twitching (increase
ICP)
4/28/12
effects
4/28/12
Management: hypervolemia
Water restriction (1500 ml/day) Diuretics Sodium restrictions Albumin infusion Supportive care cardiac, pulmonary,
renal
4/28/12
CONCENTRATION CHANGES
Changes in the concentration of
concentration
HYPONATREMIA or HYPERNATREMIA
4/28/12
HYPONATREMIA
Low or decreased sodium
concentration
Dilutional or overhydration especially
in surgical patients
Hyperglycemia Conditions that expands plasma
volume
4/28/12
HYPONATREMIA
4/28/12
HYPONATREMIA
Pathophysiology/Clinical
Manifestations:
Acute hyponatremia
CNS Manifestations
Brain
Seizures,
Increased
Hypertension
4/28/12
HYPONATREMIA
Hyponatremia becomes symptomatic
if the serum sodium level becomes < 120 meq/L (slow) or < 130 meq/L (rapidly)
4/28/12
HYPONATREMIA
Management
Water restriction Sodium replacement Optimize renal function Control of other contributing factors (eg.
Hyperglycemia)
HYPERNATREMIA
Uncommon; usually dangerous Etiology:
Excessive or unexpected isotonic volume
loss
Evaporative Head
Osmotic diuresis Uncontrolled hyperglycemia during TPN High output renal failure
4/28/12
HYPERNATREMIA
4/28/12
HYPERNATREMIA
Pathophysiology/Clinical
Manifestations
Profound ECF volume deficit CNS signs and symptoms
Restlessness Dry
and Delirium
Flushed High
Oliguria
HYPERNATREMIA
Management
Volume replacement to give dilutional
effect
4/28/12
4/28/12
COMPOSITIONAL CHANGES
ACID-BASE BALANCE SPECIFIC ELECTROLYTE CHANGES
POTASSIUM CALCIUM MAGNESIUM Other electrolytes
4/28/12
ACID-BASE BALANCE
Goal is to maintain pH between 7.35
4/28/12
ACID-BASE BALANCE
THREE PRIMARY BODY BUFFER
SYSTEMS
BICARBONATE-CARBONIC ACID BUFFER
SYSTEM
RESPIRATORY BUFFER SYSTEM RENAL BUFFER SYSTEM
4/28/12
Buffer systems
Bicarbonate-Carbonic Acid Buffer
System
Occurring inside the red blood cells Most important and rapid Based on the Henderson-Hasselbalchs
Equation
pH
4/28/12
Buffer system
Respiratory buffer system
Function of the ventilation/respiratory
system gas)
Elimination of carbon dioxide (volatile Rapid and inexhaustible system Will function as long as ventilation not
compromised
4/28/12
Buffer system
Renal buffer system
Function
Extraction
Reclamation De
Slow
Compromise
ACID-BASE DISORDERS
minimum of laboratory data (usually starts with the diagnosis of the main disease)
Arterial Blood Gas Analysis is very
important
Serum Electrolyte determination Management principles:
Treat the underlying cause giving rise to
Acid-Base Disorders
Metabolic Alkalosis
Respiratory Alkalosis
7. 4
4/28/12
4/28/12
Respiratory Acidosis
Retention of carbon dioxide =
inadequate ventilation
4/28/12
Respiratory Acidosis
Etiology:
Any condition that may cause
inadequate ventilation
Airway COPD Pneumonia CNS
obstruction
Respiratory
morphine)
Thoracic
injury
4/28/12
Respiratory acidosis
Diagnosis:
Clinical history and physical examination ABG: decresed pH, increased pCO2 Acute state: normal HCO3 Chronic state: elevated HCO3 Clinical manifestations largely depends
Respiratory acidosis
Management:
Treatment of underlying etiology Any measure to improve ventilation
Intubation Mechanical
ventilator
Supportive measures
Manage
4/28/12
Respiratory Alkalosis
Acute or chronic hyperventilation Increased in expulsion of CO2 Etiology:
Apprehension/anxiety Pain (postoperative) Hypoxia Pulmonary embolism CNS injuries/infections Assisted/mechanical ventilation
4/28/12
Respiratory alkalosis
Diagnosis:
ABG: decreased pCO2, increased pH
Dangers / Complications:
Potassium depletion = cardiac
complications
cerebral vasoconstriction
Others:
Depressed O2 delivery to tissues
4/28/12
Respiratory alkalosis
Management:
Difficult and with poor prognosis in
4/28/12
Metabolic Acidosis
Retention / overproduction of acids
Azotemia Diabetic ketoacidosis Lactic acidosis
Loss of bicarbonate
Diarrhea Pancreatic or small bowel fistulas
4/28/12
Metabolic acidosis
Characterized by calculated anion
acid
4/28/12
4/28/12
Metabolic acidosis
Management:
Correct the underlying cause Volume resuscitation Treatment of sepsis/infection
4/28/12
Metabolic Alkalosis
Loss of acid and gain of base Usually aggravated by hypokalemia
4/28/12
4/28/12
Metabolic alkalosis
Diagnosis:
ABG: increased HCO3 and pH Compensatory hypercapnia (increased
pCO2)
Hypokalemia
Management:
Treat underlying cause Correct hypovolemia with chloride-
Potassium Abnormalities
K+ is the major ICF cation; the small
mEq/ L
4/28/12
4/28/12
uptake esp. in acute alkalosis, insulin treatment and anabolism steroids use, renal tubular acidosis
4/28/12
Hypokalemia
Diagnosis:
S / S: Muscle weakness, hyporeflexia,
4/28/12
Hypokalemia
Management:
Check renal function before treatment Treat alkalosis if present; decrease
sodium intake
Enteral replacement is preferred: 20 40
mEq
KCl elixir : 15 cc = 20 mEq KCl Potassium tablet = 8 mEq KCl Parenteral replacement:
4/28/12
hemolysis, thrombocytosis
4/28/12
Hyperkalemia
Diagnosis:
Clinical S / S: nausea, vomiting,
4/28/12
Hyperkalemia
Management:
Remove exogenous source of
bicarbonate or base
4/28/12
Calcium Abnormalities
Calcium is essential for
dL
2 types :
Non-ionized form
55%
bound
Ionized form
HYPOCALCEMIA
Etiology:
Acute pancreatitis Necrotising fascitis Acute and chronic renal failure Pancreatic and small intestinal fistulas Hypoparathyroidism After surgical removal or
Hypocalcemia
Clinical manifestations:
Usually asymptomatic until level is below
8 mg / dL
Hypocalcemia
Management:
Correction of underlying cause and
replacement of deficit
4/28/12
HYPERCALCEMIA
Etiology:
Malignancy Hyperparathyroidism Acute adrenal insufficiency Pagets disease Prolonged immobilization Hyperthyroidism
4/28/12
Hypercalcemia
Clinical manifestations:
Acute
Bones Moans Abdominal groans Psychic overtones Nausea, vomiting, anorexia Constipation, polyuria Confusion, lethargy
4/28/12
Hypercalcemia
Management:
Acute crisis must be managed urgently Hydration; rapid ECF volume repletion to
Loop diuretics furosemide Mithramycin intravenously Hemodialysis Calcitonin Parathyroidectomy (if due to
hyperparathyroidism)
4/28/12
MAGNESSIUM ABNORMALITIES
Magnessium ion needed in most
enzymatic systems and depletion may lead to neuromuscular and CNS hyperactivity
4/28/12
MAGNESSIUM DEFFICIENCY
Etiology:
Complication of malnutrition Starvation Malabsorption syndromes Acute pancreatitis Diabetic ketoacidosis GI fluid losses Prolonged parenteral nutrition and
hyperalimentation
Primary aldosteronism
4/28/12
Magnessium deficiency
Clinical manifestations:
Diagnosis based on high index of Similar to calcium deficiency
suspicion clinical and laboratory hyperreflexia, muscle tremors, and tetany with Chvosteks sign
4/28/12
Magnessium deficiency
Management:
Magnessium replacement : parenteral
4/28/12
MAGNESSIUM EXCESS
Etiology:
Renal failure Antacid overuse Hypothyroidism Adrenal insufficieny
4/28/12
Magnessium excess
Clinical manifestations:
Nausea and vomiting Weakness Mental status changes Hyper-reflexia Hyperventilation
4/28/12
Magnessium excess
Management:
Remove or discontinue possible external
sources cases
4/28/12
4/28/12
4/28/12
4/28/12
Phosphate
HYPOPHOSPHATEMIA
Etiology:
TPN DM
nutrition
ketoacidosis
Starvation Prolonged
Phosphate
HYPOPHOSPHATEMIA
Clinical manifestations:
Myocardial Anorexia Bone
depression
pain
changes replacement
Management:
Parenteral 4/28/12
Phosphate
HYPERPHOSPHATEMIA
Etiology:
Renal
insufficiency
D metabolites
source antacids
4/28/12
Phosphate-binding
Zinc
Enzyme activator; 1 2 gm in the
whole body
Concentrated in the brain, pancreas,
4/28/12
4/28/12
THANK YOU
4/28/12
4/28/12
4/28/12
4/28/12
4/28/12
4/28/12
4/28/12
4/28/12